Presented by: Bausch + Lomb
Thursday, June 3 | 10:00 AM – 11:00 AM
Speakers: Mile Brujic, OD, FAAO, Michael Chaglasian, OD, FAAO
This session will provide insights and updates on Bausch & Lomb’s portfolio of innovative anti-inflammatory and IOP-reducing pharmaceuticals. The speakers will cover clinical trial data for each medication, share their real-world takeaways on clinical use, and cover important prescribing information for the treatment of patients in optometry practices.